Penicillin use in meningococcal disease management: Active bacterial core surveillance sites, 2009

Amy E. Blain*, Sema Mandal, Henry Wu, Jessica R. MacNeil, Lee H. Harrison, Monica M. Farley, Ruth Lynfield, Lisa Miller, Megin Nichols, Sue Petit, Arthur Reingold, William Schaffner, Ann Thomas, Shelley M. Zansky, Raydel Anderson, Brian H. Harcourt, Leonard W. Mayer, Thomas A. Clark, Amanda C. Cohn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.

Original languageEnglish
JournalOpen Forum Infectious Diseases
Volume3
Issue number3
DOIs
Publication statusPublished - 1 May 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author 2016.

Keywords

  • Antimicrobial resistance
  • Meningitis
  • Meningococcal disease
  • Neisseria meningitidis

Fingerprint

Dive into the research topics of 'Penicillin use in meningococcal disease management: Active bacterial core surveillance sites, 2009'. Together they form a unique fingerprint.

Cite this